 Fate Therapeutics, Inc. NASDAQ:FATE Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Scott Wolchko - President Chief Executive Officer Ed Dulac - Chief Financial Officer Bob Valamehr - Chief Research Development Officer Conference Call Participants Tazeen Ahmad - Bank of America Michael Yee - Jefferies Tyler Van Buren - Cowen Yigal Nochomovitz - Citigroup Michael Schmidt - Guggenheim Securities Daina Graybosch - SVB Securities Peter Lawson - Barclays Gil Blum - Needham Operator Welcome to the Fate Therapeutics Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. 